Connect your AI

Biote Corp. BTMD Contract Liabilities

Contract Liabilities at other companies

NAG

Niagen Bioscience, Inc. Common StockNAGE

$2.57M-0.3%

Other financials

Income statement

Revenue$44.9M-8.3%

Gross profit$31.0M-14.9%

Operating income$3.2M-67.3%

Net income$2.3M-83.4%

EPS (diluted)$0.06-83.8%

Balance sheet

Cash & equivalents$5.3M-87.2%

Total debt$103.4M-5.5%

Total equity-$56.1M+37.7%

Total assets$89.0M-27.8%

Cash flow

Operating cash flow$3.9M-39.7%

CapEx$362.0K-77.8%

Free cash flow$3.5M-26.8%

Valuation

Market cap$57.33M-51.2%

Enterprise value$155.43M-26.5%

P/E3.7×-0.1×

P/S0.3×-0.3×

Profitability

Gross margin70.1%-1.2pp

Operating margin15.4%-0.1pp

Net margin8.3%-2.3pp

FCF margin15.3%-3.2pp

Returns & leverage

Return on equity-21.4%—

Debt / equity9.1×—

Current ratio1.3×-0.1×

Where this comes from

Reported directly by Biote Corp. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biote Corp.'s contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Biote Corp.'s contract liabilities?: Biote Corp. (BTMD) reported contract liabilities of $922K in Q1 2026.
How has Biote Corp.'s contract liabilities changed year-over-year?: Biote Corp.'s contract liabilities decreased by 36.4% year-over-year, from $1.45M to $922K.
What is the long-term trend for Biote Corp.'s contract liabilities?: Over 4 years (2021 to 2025), Biote Corp.'s contract liabilities has grown at a 8.1% compound annual growth rate (CAGR), from $802K to $1.1M.
What does contract liabilities mean?: Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.